Visacor

Држава: Нови Зеланд

Језик: Енглески

Извор: Medsafe (Medicines Safety Authority)

Активни састојак:

Rosuvastatin calcium 10.4mg equivalent to 10 mg rosuvastatin

Доступно од:

AstraZeneca Limited

INN (Међународно име):

Rosuvastatin calcium 10.4 mg (= 10 mg rosuvastatin)

Дозирање:

10 mg

Фармацеутски облик:

Film coated tablet

Састав:

Active: Rosuvastatin calcium 10.4mg equivalent to 10 mg rosuvastatin Excipient: Calcium phosphate Crospovidone Hypromellose as Opadry Pink Iron oxide red as Opadry Pink Lactose monohydrate as Opadry Pink   Magnesium stearate Microcrystalline cellulose Titanium dioxide as Opadry Pink Triacetin as Opadry Pink

Јединице у пакету:

Blister pack, Al/Al foil, 7 tablets

Класа:

Prescription

Тип рецептора:

Prescription

Произведен од:

IPR Pharmaceuticals Inc

Терапеутске индикације:

VISACOR is indicated to: - Reduce elevated LDL-C, Total Cholesterol, triglycerides and to increase HDLcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (Fredrickson Types IIa and IIb). - Treat isolated hypertriglyceridaemia (Fredrickson Type IV hyperlipidaemia). Reduce Total Cholesterol and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. LDL apheresis) or alone if such treatments are unavailable.

Резиме производа:

Package - Contents - Shelf Life: Blister pack, Al/Al foil - 7 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al foil - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Датум одобрења:

2009-07-31